Area of research
Hepatology · Epidemiology
Research interest
Research interests include Medicine, Hepatocellular carcinoma, Internal medicine, Sorafenib, Cancer research, and Regorafenib.
Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation
Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes‐Associated Protein 1 Activation and Transient Expansion of Stem‐Like Cancer Cells
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study
Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis
Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma
Systemic treatment of HCC in special populations
BAX Redistribution Induces Apoptosis Resistance and Selective Stress Sensitivity in Human HCC
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients
High pretreatment static and dynamic alpha‐fetoprotein values predict reduced overall survival in hepatocellular carcinoma
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation
Context-Dependent Role of NF-κB Signaling in Primary Liver Cancer—from Tumor Development to Therapeutic Implications
The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and Immunotherapies
Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers
Immunotherapy of Hepatocellular Carcinoma
Application of patient‐derived liver cancer cells for phenotypic characterization and therapeutic target identification
Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas